Gossamer Bio Announces 1-for-80 Reverse Stock Split to Regain Nasdaq Compliance Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on developing and commercializing seralutinib for pulmonary vascular diseases, has announced that its Board of Directors has selected a…
Nanochon Treats First Patient in First-in-Human Clinical Study of Chondrograft for Knee Cartilage Defects Nanochon, a medical device company developing innovative solutions for cartilage repair, has announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study…
Sarepta Therapeutics Announces 25 Recipients of Route 79 Duchenne Scholarship Program for 2026-2027 Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a company focused on precision genetic medicine for rare diseases, has announced the 25 recipients of its Route 79, The Duchenne Scholarship…
Lineage Cell Therapeutics Receives U.S. Patent Covering AlloSCOPE 5D Cell Manufacturing Platform Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company focused on developing novel allogeneic, “off-the-shelf” cell therapies for serious medical conditions, has announced an…
RiboX Therapeutics Receives FDA RMAT Designation for RXRG001 in Radiation-Induced Xerostomia RiboX Therapeutics, a clinical-stage biotechnology company focused on discovering and developing fully engineered circular RNA (circRNA) therapeutics, announced that the U.S. Food and Drug Administration (FDA) has granted Regenerative…
Dunbar Pharmaceuticals to Showcase Pharmaceutical-Grade Plant-Derived Dronabinol at expopharm 2026 Dunbar Pharmaceuticals, also known as Dunbar Pharma, is set to participate in expopharm 2026, one of Europe’s leading trade fairs for the pharmacy sector, as the company continues to expand…
Teleflex Highlights Advanced Vascular Technologies at CIRSE 2026, Featuring Dynetic™-35 Stent System Teleflex Incorporated, a global provider of medical technologies, is set to showcase a range of innovative solutions at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2026…
Stoke Therapeutics and Biogen Present Long-Term Zorevunersen Data Supporting Potential Disease-Modifying Treatment for Dravet Syndrome Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company focused on restoring protein expression through RNA medicine, and Biogen Inc. (Nasdaq: BIIB) have announced the presentation…
Invivoscribe Begins Commercial Shipments of PrepQuant™ System to Advance High-Sensitivity MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, has announced the start of commercial shipments of its PrepQuant™ System in North America. The…
Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader for Routine Laboratory Applications Thermo Fisher Scientific has announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, a new single-mode absorbance microplate reader designed to support a broad…
Transcat Acquires Southeastern Biomedical Associates for $12.8 Million to Expand Biomedical Calibration Services Transcat, Inc., a provider of accredited calibration services and test and measurement equipment, has announced the acquisition of privately held Southeastern Biomedical Associates Incorporated, a move designed…
Cardio Diagnostics Releases Updated Rural Health Report Focused on Improving Cardiovascular Care and Access Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an artificial intelligence-driven precision cardiovascular medicine company, has released an updated edition of its report examining the state of rural…